Ou Bai, Md/phd
Clinical trials sponsored by Ou Bai, Md/phd, explained in plain language.
-
New hope for elderly lymphoma patients: targeted combo therapy shows promise
Disease control Recruiting nowThis study tests a new drug combination for elderly patients (70+) with a specific type of aggressive lymphoma called double-expressor DLBCL. The treatment includes a targeted drug (chidamide) plus a reduced-intensity chemotherapy, followed by maintenance therapy. The goal is to …
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
New hope for lymphoma patients with hepatitis b: maintenance drug aims to prevent relapse
Disease control Recruiting nowThis study tests whether the drug chidamide can help prevent diffuse large B-cell lymphoma (DLBCL) from coming back in patients who also have hepatitis B and have already responded well to initial chemotherapy (R-CHOP). About 200 adults aged 18–80 will take chidamide as a mainten…
Phase: PHASE3 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 15, 2026 11:56 UTC